GIRGENTI STEVEN 4
4 · bioAffinity Technologies, Inc. · Filed Apr 24, 2024
Insider Transaction Report
Form 4
GIRGENTI STEVEN
DirectorExecutive Chairman
Transactions
- Tax Payment
Common Stock
2024-04-03$2.24/sh−33,438$74,901→ 1,023,168 total - Exercise/Conversion
Common Stock
2024-04-03$1.16/sh+64,848$75,224→ 1,056,606 total - Exercise/Conversion
Stock Option (right to buy)
2024-04-03−64,848→ 0 totalExercise: $1.16Exp: 2024-04-28→ Common Stock (64,848 underlying)
Holdings
- 8,955(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Represents shares withheld to cover the exercise price of the options exercised.
- [F2]These shares are owned directly by the Cranye Girgenti Testamentary Trust (the "Trust"). The reporting person is a co-trustee of the Trust. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F3]This option vested in 7 equal monthly installments beginning on April 28, 2014.